0 NASDAQ Companies - November 12, 2024Montauk Renewables Announces Third Quarter 2024 ResultsPITTSBURGH, Nov. 12, 2024 (GLOBE NEWSWIRE) — Montauk Renewables, Inc. (“Montauk” or “the Company”) (NASDAQ: MNTK), a renewable energy company […]Read More
0 TSX Venture News - November 12, 2024Carbeeza Inc. Announces Management TransitionCALGARY, Alberta, Nov. 12, 2024 (GLOBE NEWSWIRE) — Carbeeza Inc. (“Carbeeza” or the “Company“) (TSXV:AUTO) (OTCQB: CRBAF) announces a senior […]Read More
0 NYSE Companies - November 12, 2024Toll Brothers’ Website to Broadcast Its Fourth Quarter 2024 Earnings Conference Call Live on December 10, 2024 at 8:30 a.m. (ET)FORT WASHINGTON, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, […]Read More
0 NASDAQ Companies - November 12, 2024IN8bio Reports Third Quarter 2024 Financial Results and Recent Corporate HighlightsReported 100% of Acute Myeloid Leukemia (AML) patients treated in INB-100 remain in complete remission (CR) at the 2024 European […]Read More
0 NASDAQ Companies - November 12, 2024Synchronoss Technologies to Present at Upcoming Investor ConferencesBRIDGEWATER, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) — Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader […]Read More
0 NASDAQ Companies - November 12, 2024LGI Homes Announces Pricing of $400 Million of Unsecured Senior Notes due 2032THE WOODLANDS, Texas, Nov. 12, 2024 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) (“LGI Homes” or the “Company”) today […]Read More
0 NASDAQ Companies - November 12, 2024CarGurus to Present at RBC Capital Markets 2024 Global Technology, Internet, Media and Telecommunications ConferenceBOSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) — CarGurus, Inc. (Nasdaq: CARG), the No. 1 visited digital auto platform for shopping, […]Read More
0 NASDAQ Companies - November 12, 2024Tempest Reports Third Quarter 2024 Financial Results and Provides Business UpdateBuilding upon a successful end-of-Phase 2 meeting, received FDA “Study May Proceed” letter for pivotal Phase 3 trial of amezalpat […]Read More
0 NASDAQ Companies - November 12, 2024FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate UpdatePreparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are […]Read More
0 NYSE Companies - November 12, 2024TEN, Ltd. Announces Date for the Third Quarter 2024 Results, Conference Call and WebcastATHENS, Greece, Nov. 12, 2024 (GLOBE NEWSWIRE) — TEN Ltd. (“TEN”) (NYSE: TEN) (the “Company”), a leading diversified crude, product […]Read More